Patent Licensing Deals Could Be More Costly Under FTC Proposed Rules
Executive Summary
Federal Trade Commission is proposing to amend pre-merger notification rules related to the transfer of exclusive patent rights in the pharmaceutical industry; the change would require reporting transactions in which the licensor retains exclusive manufacturing rights.